On March 31, 2026, Aptose Biosciences Inc. shareholders overwhelmingly approved a continuation to the Business Corporations Act in Alberta and a plan for HS North America Ltd. to acquire outstanding shares not held by them, with 92.42% and 84.87% voting in favor, respectively.